Device-Enabled Therapeutics Although not drugs per se, innovations like Dexcom G7 CGM and automated insulin delivery systems (e.g., Control-IQ+) significantly influence treatment strategies - particularly for patients requiring insulin
The scientists focused on three key genesMYB, HDAC2, and FOXA2that act like switches helping cancer cells stay undifferentiated and grow uncontrollably
None of the Marketing Authorisation Holders in the UK use any clinical evidence for optimal dosage of 3 monthly treatment and base the information written in their Patient Information Leaflet upon BNF Guidelines and the Martindale Drug Reference book
Lean into your structured meal plan rather than trying to eat intuitively
BPC-157 is under FDA advisory review in July 2026, and FDA staff documents recommend caution because human safety and effectiveness data are limited
And then probably most importantly, if we stop a medication, how do we deal with weight regain
